U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H30N2O5
Molecular Weight 378.4626
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEOTAME

SMILES

COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NCCC(C)(C)C

InChI

InChIKey=HLIAVLHNDJUHFG-HOTGVXAUSA-N
InChI=1S/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H30N2O5
Molecular Weight 378.4626
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Neotame is a derivative of a dipeptide compound of the amino acids - aspartic acid and phenylalanine. Neotame has been developed as a sweetener with a high degree of sweetness and is obtained by N-alkylating aspartame. Its degree of sweetness varies according to the kind of food and blend composition. It is 7000 to 13,000 times and about 30 to 60 times sweeter than sugar and aspartame respectively. Neotame is rapidly metabolized, completely eliminated and does not accumulate in the body. The major metabolic pathway of neotame is hydrolysis of the methyl ester by esterase which is present throughout the body. This yields de-esterified neotame, the major metabolite and a significant amount of methanol. Due to the presence of the 3-3-di-methylbutyl group, peptidases which would typically break the peptide bond between the aspartic acid and phenylalanine moieties are essentially blocked, thus reducing the availability of phenylalanine. Neotame was approved by the USFDA as a general purpose sweetener in July 2002

Approval Year

PubMed

PubMed

TitleDatePubMed
[Simultaneous determination of six synthetic sweeteners in food by high performance liquid chromatography-tandem mass spectrometry].
2010-11
Retention behaviour of some high-intensity sweeteners on different SPE sorbents.
2010-10-15
Characterization of the beta-D-glucopyranoside binding site of the human bitter taste receptor hTAS2R16.
2010-09-03
Determination of neotame in beverages, cakes and preserved fruits by column-switching high-performance liquid chromatography.
2010-09
[Determination of five synthetic sweeteners in wines using high performance liquid chromatography-tandem mass spectrometry].
2010-08
Gain weight by "going diet?" Artificial sweeteners and the neurobiology of sugar cravings: Neuroscience 2010.
2010-06
Key amino acid residues involved in multi-point binding interactions between brazzein, a sweet protein, and the T1R2-T1R3 human sweet receptor.
2010-05-14
Positive allosteric modulators of the human sweet taste receptor enhance sweet taste.
2010-03-09
Standards of medical care in diabetes--2010.
2010-01
Analysis and occurrence of seven artificial sweeteners in German waste water and surface water and in soil aquifer treatment (SAT).
2009-07
Determination of nine intense sweeteners in foodstuffs by high-performance liquid chromatography and evaporative light-scattering detection: interlaboratory study.
2009-04-23
Simultaneous determination of nonnutritive sweeteners in foods by HPLC/ESI-MS.
2009-04-22
Analyses of sweet receptor gene (Tas1r2) and preference for sweet stimuli in species of Carnivora.
2009-04-16
[Simultaneous determination of artificial sweeteners in beverage by ultra performance liquid chromatography].
2009-01
Standards of medical care in diabetes--2009.
2009-01
Development of rebiana, a natural, non-caloric sweetener.
2008-07
The potential toxicity of artificial sweeteners.
2008-06
[Simultaneous determination of neotame, alitame and aspartame in foods by HPLC].
2008-02
The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor.
2007-10-12
Simultaneous determination of nine intense sweeteners in foodstuffs by high performance liquid chromatography and evaporative light scattering detection--development and single-laboratory validation.
2007-07-20
Artificial sweeteners: no calories...sweet!
2007-01-25
Taste responses to sweet stimuli in alpha-gustducin knockout and wild-type mice.
2006-07
The G protein-coupled receptor subset of the chicken genome.
2006-06-02
The heterodimeric sweet taste receptor has multiple potential ligand binding sites.
2006
Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy.
2005-12
Artificial sweeteners--do they bear a carcinogenic risk?
2004-10
Different functional roles of T1R subunits in the heteromeric taste receptors.
2004-09-28
Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners.
2004-02
[Effect of food additive Neotame (N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine-1-methyl) on glucose level in blood of patients with diabetes mellitus type 2].
2004
Evaluation of certain food additives and contaminants.
2004
Long-term food consumption and body weight changes in neotame safety studies are consistent with the allometric relationship observed for other sweeteners and during dietary restrictions.
2003-10
Food consumption and body weight changes with neotame, a new sweetener with intense taste: differentiating effects of palatability from toxicity in dietary safety studies.
2003-10
Crystal structure of neotame anhydrate polymorph G.
2002-10
Neotame anhydrate polymorphs. II: Quantitation and relative physical stability.
2002-09
Conformational flexibility and hydrogen-bonding patterns of the neotame molecule in its various solid forms.
2002-09
Neotame - a new artificial sweetener.
2002-08-19
Dehydration kinetics of neotame monohydrate.
2002-06
Neotame anhydrate polymorphs I: preparation and characterization.
2002-03
Structure, dynamics, and stability of beta-cyclodextrin inclusion complexes of aspartame and neotame.
2001-04
Modifying the temporal profile of the high-potency sweetener neotame.
2001-02
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:49:09 GMT 2025
Edited
by admin
on Mon Mar 31 18:49:09 GMT 2025
Record UNII
VJ597D52EX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
E 961
Preferred Name English
NEOTAME
FCC   FHFI   II   INCI   MART.   MI  
INCI  
Official Name English
NEOTAME [FHFI]
Common Name English
N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-L-PHENYLALANINE 1-METHYL ESTER
Common Name English
NC-00723
Code English
INS-961
Code English
NEOTAME [USP-RS]
Common Name English
INS NO.961
Code English
NEOTAME [MI]
Common Name English
NEOTAME [MART.]
Common Name English
L-PHENYLALANINE, N-(N-(3,3-DIMETHYLBUTYL)-L-.ALPHA.-ASPARTYL)-1-METHYL ESTER
Common Name English
NEOTAME [II]
Common Name English
MIRASEE 200
Common Name English
NEOTAME [FCC]
Common Name English
E-961
Code English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-961
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
JECFA EVALUATION INS-961
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
NCI_THESAURUS C283
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
CFR 21 CFR 172.829
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
Code System Code Type Description
EVMPD
SUB119863
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
WIKIPEDIA
NEOTAME
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
RS_ITEM_NUM
1460204
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
FDA UNII
VJ597D52EX
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID50167950
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
SMS_ID
100000143306
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
DAILYMED
VJ597D52EX
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
MERCK INDEX
m7820
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY Merck Index
PUBCHEM
9810996
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
HSDB
7965
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
CAS
165450-17-9
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
NCI_THESAURUS
C81625
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY
RXCUI
1367111
Created by admin on Mon Mar 31 18:49:09 GMT 2025 , Edited by admin on Mon Mar 31 18:49:09 GMT 2025
PRIMARY RxNorm
Related Record Type Details
TARGET -> AGONIST